377 related articles for article (PubMed ID: 7631125)
1. Evaluation of suramin, ivermectin and CGP 20376 in a new macrofilaricidal drug screen, Onchocerca ochengi in African cattle.
Renz A; Trees AJ; Achu-Kwi D; Edwards G; Wahl G
Trop Med Parasitol; 1995 Mar; 46(1):31-7. PubMed ID: 7631125
[TBL] [Abstract][Full Text] [Related]
2. Effects of an injectable long-acting formulation of ivermectin on Onchocerca ochengi in zebu cattle.
Boussinesq M; Enyong P; Chounna-Ndongmo P; Njouendou AJ; Pion SD; Rech A; Roberge C; Gaudriault G; Wanji S
Parasite; 2020; 27():36. PubMed ID: 32420864
[TBL] [Abstract][Full Text] [Related]
3. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
[TBL] [Abstract][Full Text] [Related]
4. The entry of ivermectin and suramin into Onchocerca ochengi nodules.
Cross HF; Bronsvoort BM; Wahl G; Renz A; Achu-Kwi D; Trees AJ
Ann Trop Med Parasitol; 1997 Jun; 91(4):393-401. PubMed ID: 9290846
[TBL] [Abstract][Full Text] [Related]
5. Suramin in the treatment of onchocerciasis: the efficacy of low doses on the parasite in an area with vector control.
Schulz-Key H; Karam M; Prost A
Trop Med Parasitol; 1985 Dec; 36(4):244-8. PubMed ID: 4089476
[TBL] [Abstract][Full Text] [Related]
6. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.
Awadzi K; Attah SK; Addy ET; Opoku NO; Quartey BT; Lazdins-Helds JK; Ahmed K; Boatin BA; Boakye DA; Edwards G
Ann Trop Med Parasitol; 2004 Jun; 98(4):359-70. PubMed ID: 15228717
[TBL] [Abstract][Full Text] [Related]
7. Animal models--Onchocerca ochengi and the development of chemotherapeutic and chemoprophylactic agents for onchocerciasis.
Trees AJ; Wood VL; Bronsvoort M; Renz A; Tanya VN
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S175-9. PubMed ID: 9861291
[No Abstract] [Full Text] [Related]
8. Chemoprophylaxis of Onchocerca infections: in a controlled, prospective study ivermectin prevents calves becoming infected with O. ochengi.
Tchakouté VL; Bronsvoort M; Tanya V; Renz A; Trees AJ
Parasitology; 1999 Feb; 118 ( Pt 2)():195-9. PubMed ID: 10028534
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of an Onchocerca ochengi microfilarial hamster model for onchocerciasis drug screens.
Mbah GE; Ayiseh RB; Cho-Ngwa F
BMC Infect Dis; 2016 Aug; 16(1):404. PubMed ID: 27515037
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of implanted male Onchocerca gibsoni in mice as a screen for macrofilaricides against Onchocerca volvulus.
Vankan DM; Copeman DB; Novak M
Trop Med Parasitol; 1988 Dec; 39 Suppl 4():472-4. PubMed ID: 3227248
[TBL] [Abstract][Full Text] [Related]
11. The embryogenesis of Onchocerca volvulus over the first year after a single dose of ivermectin.
Duke BO; Zea-Flores G; Muñoz B
Trop Med Parasitol; 1991 Sep; 42(3):175-80. PubMed ID: 1801140
[TBL] [Abstract][Full Text] [Related]
12. Emergence of Onchocerca volvulus microfilariae from skin snips before and after treatment of patients with ivermectin.
Mössinger J; Schulz-Key H; Dietz K
Trop Med Parasitol; 1988 Dec; 39(4):313-6. PubMed ID: 3067322
[TBL] [Abstract][Full Text] [Related]
13. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
Bulman CA; Bidlow CM; Lustigman S; Cho-Ngwa F; Williams D; Rascón AA; Tricoche N; Samje M; Bell A; Suzuki B; Lim KC; Supakorndej N; Supakorndej P; Wolfe AR; Knudsen GM; Chen S; Wilson C; Ang KH; Arkin M; Gut J; Franklin C; Marcellino C; McKerrow JH; Debnath A; Sakanari JA
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003534. PubMed ID: 25700363
[TBL] [Abstract][Full Text] [Related]
14. The safety and efficacy of amocarzine in African onchocerciasis and the influence of ivermectin on the clinical and parasitological response to treatment.
Awadzi K; Opoku NO; Attah SK; Addy ET; Duke BO; Nyame PK; Kshirsagar NA
Ann Trop Med Parasitol; 1997 Apr; 91(3):281-96. PubMed ID: 9229021
[TBL] [Abstract][Full Text] [Related]
15. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.
Awadzi K; Dadzie KY; Shulz-Key H; Haddock DR; Gilles HM; Aziz MA
Ann Trop Med Parasitol; 1985 Feb; 79(1):63-78. PubMed ID: 3838638
[TBL] [Abstract][Full Text] [Related]
16. Suramin and the time it takes to kill Onchocerca volvulus.
Duke BO
Trop Med Parasitol; 1991 Dec; 42(4):346-50. PubMed ID: 1796231
[TBL] [Abstract][Full Text] [Related]
17. Anti-Onchocerca activity and phytochemical analysis of an essential oil from Cyperus articulatus L.
Metuge JA; Nyongbela KD; Mbah JA; Samje M; Fotso G; Babiaka SB; Cho-Ngwa F
BMC Complement Altern Med; 2014 Jul; 14():223. PubMed ID: 24998345
[TBL] [Abstract][Full Text] [Related]
18. Cattle protected from onchocerciasis by ivermectin are highly susceptible to infection after drug withdrawal.
Njongmeta LM; Nfon CK; Gilbert J; Makepeace BL; Tanya VN; Trees AJ
Int J Parasitol; 2004 Aug; 34(9):1069-74. PubMed ID: 15313133
[TBL] [Abstract][Full Text] [Related]
19. The use of monoclonal antibody-based ELISAs to monitor chemotherapeutic effects in the bovine-Onchocerca gibsoni drug screen.
More SJ; Copeman DB
Trop Med Parasitol; 1991 Mar; 42(1):17-20. PubMed ID: 2052850
[TBL] [Abstract][Full Text] [Related]
20. The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients.
Awadzi K; Attah SK; Addy ET; Opoku NO; Quartey BT
Trans R Soc Trop Med Hyg; 1999; 93(2):189-94. PubMed ID: 10450448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
